STUDENT SUCCESS

Three students stand in a row smiling while holding plaques and a trophy.

Rylee Pitts, Hannah Kempker and Claire Vogl show off the championship trophy they brought home to the School of Pharmacy.

UMKC students win clinical skills competition

UMKC Pharmacy students Hannah Kempker, Claire Vogl and Rylee Pitts took home the top prize at the American College of Clinical Pharmacy’s 2023 Clinical Pharmacy Challenge in November.

The multi-round competition spanned several months and culminated with a live event in Dallas, Texas. After a close championship round, UMKC won on the final question and took home $1,500 in prize money, plus a commemorative trophy.

Known for its “quiz-bowl” style, the challenge included rounds featuring general pharmacy trivia, a clinical case study and final jeopardy. Teams began their journey with virtual rounds – only the top eight ranking teams traveled to Dallas to compete.

“Online versus in-person rounds are a different game,” Kempker said. “[With] online rounds, you have more time to think critically and reason through a question. In person, you have to rely on all knowledge from didactic coursework and rotations to quickly come up with an answer and stick with it.”

Preparing for the competition was an all-hands-on-deck effort.

“Generally, we looked through the ACCP pocket guide, the APhA review book and our old pharmacotherapy notes,” Vogl said. “We also tried to look at specific jeopardy categories as the rounds progressed, focusing on categories we hadn’t seen yet to prepare for the next round.”

Kempker added, “I think the biggest thing we did to prepare was to talk about our strategy.”

The team’s friendship and knowledge of each other’s strengths were a big part of their success in such an intense, competitive environment.

“Because we are all close, we also know each other’s tendencies and hesitations, so that helped when we moved into the live buzzer rounds,” Vogl said. “One person might buzz for the other because we knew they might be more hesitant.”

Elizabeth Englin, Pharm.D., was the team’s faculty mentor and was there to support them in Dallas.

“It was so fun to watch them, and they were so strategic in their play,” Englin said. “You could tell they were friends, and they work so well as a team… They’re just wonderful students all around.”

Portrait of Cassandra Van Horn

Pharmacy student Cassandra Van Horn

Student finds inspiration in mentorship and summer research fellowship

Like many students, Cassandra Van Horn hadn’t decided which path she would take as a pharmacist when she entered the UMKC School of Pharmacy four years ago. But she was certain of one thing.

“I knew that I didn’t want to do a traditional hospital job or retail job in pharmacy,” she said. “It really started me thinking about research.”

Van Horn, who graduated May 2024, was one of five students selected to participate in the first-ever, summer-long pre-doctoral fellowship program in pharmacy research in 2022.

Dean Russell Melchert said the goal of the program is to give qualified students hands-on research experience while providing them with a competitive stipend during the summer semester, ultimately increasing the number of pharmacy-trained research scientists.

“We believe that this approach has the potential to positively impact the pipeline of pharmacists going into graduate programs and postdoctoral fellowships and ultimately research careers,” Melchert said.

One student participated in the second year of the program in 2023, and Melchert said the school has been contacted by several current students interested in participating in the program this upcoming summer.

In time, the plan is to expand the program to award research fellowships at each of the school’s campuses in Kansas City, Columbia and Springfield. Partially funded by alumni donations, the first year of the summer program produced a diverse range of projects, from cancer therapeutics to novel printed stents for treating cardiovascular disease.

“We want to enable the kind of learning that comes from engaging with difficult problems in a collaborative research setting,” said Gerald Wyckoff, Ph.D., director of research and graduate studies. “The fellows can then see how their training in the Pharm.D. program enables them to have a place in the wide ecosystem of pharmaceutical sciences research.”

Van Horn had the added benefit of working with School of Pharmacy alumna Janelle Sabo (Pharm.D. ’00) as a mentor as part of the Dean’s Council Mentorship Program, which pairs School of Pharmacy alumni mentors with students.

Sabo, the 2022 School of Pharmacy Alumni Award winner, is the global head of clinical innovation, system and clinical supply chain at Eli Lilly and Co. She has been accountable for the overall development, registration and launch of anti-COVID-19 therapeutics across the globe.

“It started for me when I joined the dean’s mentorship program and got paired with Dr. Sabo,” Van Horn said. “Just speaking with her, learning about her experience at UMKC, seeing how that panned out and what she does currently was very inspiring. Dr. Sabo was really a huge part of my decision to join the fellowship program.”

During her fellowship, Van Horn worked with School of Pharmacy research scientist Chi Lee, Ph.D., on a project exploring the development of cardiac stents through 3D printing. The research included a special focus on the effect of COVID-19 on patients who experience cardiac stent thrombosis.

Once the pair decided on the topic, Van Horn said she was given the reins to manage her research, under Lee’s guidance.

“I got to decide what I wanted to write on and met with Dr. Lee for his feedback,” she said. “I sent him what I had been working on, and then we discussed it. I think that helped me grow as a student and professionally, because in future practice we’re not going to be given a detailed list of, ‘this what we need to do.’ We’re going to have to generate that ourselves, so that really helped me to see a project from start to finish.”

Van Horn said that for students interested in industry pharmacy, the value of having an alumni mentor and taking part in the summer research experience is priceless.

“I got to work on my research skills. I got to work on my networking skills. I got to work on my presentation skills,” Van Horn said. “It’s really preparing me in general. All the skills I’ve learned will be applicable moving forward, and that’s incredibly valuable.”

This year, the university conferred 13 Doctor of Philosophy degrees in pharmaceutical sciences:

2023 Career Placement, Discipline of Pharmaceutical Sciences

SEMESTER, YEAR GRADUATED
STUDENT
NAME
DISSERTATION TITLE
ADVISOR
CAREER PLACEMENT
SP23

Pratik Adhikary

“Protein And Peptide-Based Biomaterials for Treatment of Covid-19, as Shuttles that Cross the Blood-Brain Barrier and Local Delivery of Antibiotics”

Kun Cheng, Ph.D.

Pharmaceutical Development Scientist I, Catalent Pharma Solutions - Kansas City, Missouri

SP23

Swetha Chintala

“Chemical Approaches for the Development of Stable Glucagons for Bi-Hormonal Antidiabetic Therapy”

Simon Friedman, Ph.D.

Postdoctoral Scholar, Department of Chemistry and Biochemistry, University of California San Diego - San Diego, California
SP23

Aninda Dey

“Functional Analysis of TET Family 5-Methylcytosine Dioxygenases in Non-CpG DNA Demethylation”

Mridul Mukherji, Ph.D.

SP23

Shivani Gargvanshi

“Library Screening and Focused Multiomics of Antibacterial Action on Vancomycin Resistant Enterococcus Faecium”

William Gutheil, Ph.D.

Postdoctoral Fellow, UMKC School of Dentistry - Kansas City, Missouri
U23

Omowumi Akinjole

“Development of Closomer and MIBG Based Nanoformulation: Application to HIV Prevention and Neuroblastoma Therapy”

Celestin Youan, Ph.D.

Research Scientist, Children’s Mercy Research Institute (CMRI) - Kansas City, Missouri

U23

Chayan Bhattacharya

“Characterization of 5-Methylcytosine Dioxygenase TET2 and Rescue of Mutant TET2 Activity by Using urbo Co-Substrate”

Mridul Mukherji, Ph.D.

Postdoctoral Fellow, Center for Molecular Medicine and Genetics, Wayne State University - Detroit, Michigan
U23

Maryam Nakhjiri

“Discovery of a Novel PI3K Inhibitor for Advanced Prostate Cancer Therapy”

Kun Cheng, Ph.D.

Scientist II, KCAS Bioanalytical and Biomarker Services - Olathe, Kansas
FS23

Sashi Kandel

“Identification and Assessment of Peptides and Single Domain Antibodies for Cancer Therapy”

Kun Cheng, Ph.D.

FS23

Chien-Yu Lin

“Targeting Extracellular Matrix Using siRNA for the Treatment of Liver Fibrosis and Pancreatic Cancer”

Kun Cheng, Ph.D.

Postdoctoral Associate, Lab of Kun Cheng, Ph.D., UMKC School of Pharmacy - Kansas City, Missouri
FS23

Yanli Liu

“Discovery of IKBKE and CD24 siRNAs for the Treatment of Triple-Negative Breast Cancer”
Kun Cheng, Ph.D.
FS23

Umar-Farouk Mamani

“Exploring Multivalency and Chemical Modifications in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy”
Kun Cheng, Ph.D.
FS23

Nitish Mishra

“Mitigating Antibiotic-Resistant Pathogens: A Multifaceted Strategy for Novel Antibacterial Drug Development and Comprehensive LCMS/MS Applications for Diverse Therapeutic Advancements”

William Gutheil, Ph.D.

Scientist I, KCAS Bioanalytical and Biomarker Services - Olathe, Kansas
FS23

Sherin George Shaji

“Delivery of STING Agonist Using Lipid Nanoparticles and Discovery of Anti-TIGIT Peptides for Cancer Therapy”
Kun Cheng, Ph.D.

SEMESTER, YEAR GRADUATED SP23

STUDENT NAME Pratik Adhikary

DISSERTATION TITLE “Protein And Peptide-Based Biomaterials for Treatment of COVID-19, as Shuttles that Cross the Blood-Brain Barrier and Local Delivery of Antibiotics”

ADVISOR Kun Cheng, Ph.D.

CAREER PLACEMENT Pharmaceutical Development Scientist I, Catalent Pharma Solutions - Kansas City, Missouri

SEMESTER, YEAR GRADUATED SP23

STUDENT NAME Swetha Chintala

DISSERTATION TITLE “Chemical Approaches for the Development of Stable Glucagons for Bi-Hormonal Antidiabetic Therapy”

ADVISOR Simon Friedman, Ph.D.

CAREER PLACEMENT Postdoctoral Scholar, Department of Chemistry and Biochemistry, University of California San Diego - San Diego, California

SEMESTER, YEAR GRADUATED SP23

STUDENT NAME Aninda Dey

DISSERTATION TITLE “Functional Analysis of TET Family 5-Methylcytosine Dioxygenases in Non-CpG DNA Demethylation”

ADVISOR Mridul Mukherji, Ph.D.

SEMESTER, YEAR GRADUATED SP23

STUDENT NAME Shivani Gargvanshi

DISSERTATION TITLE “Library Screening and Focused Multiomics of Antibacterial Action on Vancomycin Resistant Enterococcus Faecium”

ADVISOR William Gutheil, Ph.D.

CAREER PLACEMENT Postdoctoral Fellow, UMKC School of Dentistry - Kansas City, Missouri

SEMESTER, YEAR GRADUATED U23

STUDENT NAME Omowumi Akinjole

DISSERTATION TITLE “Development of Closomer and MIBG Based Nanoformulation: Application to HIV Prevention and Neuroblastoma Therapy”

ADVISOR Celestin Youan, Ph.D.

CAREER PLACEMENT Research Scientist, Children’s Mercy Research Institute (CMRI) - Kansas City, Missouri

SEMESTER, YEAR GRADUATED U23

STUDENT NAME Chayan Bhattacharya

DISSERTATION TITLE “Characterization of 5-Methylcytosine Dioxygenase TET2 and Rescue of Mutant TET2 Activity by Using urbo Co-Substrate”

ADVISOR Mridul Mukherji, Ph.D.

CAREER PLACEMENT Postdoctoral Fellow, Center for Molecular Medicine and Genetics, Wayne State University - Detroit, Michigan

SEMESTER, YEAR GRADUATED U23

STUDENT NAME Maryam Nakhjiri

DISSERTATION TITLE “Discovery of a Novel PI3K Inhibitor for Advanced Prostate Cancer Therapy”

ADVISOR Kun Cheng, Ph.D.

CAREER PLACEMENT Scientist II, KCAS Bioanalytical and Biomarker Services - Olathe, Kansas

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Sashi Kandel

DISSERTATION TITLE “Identification and Assessment of Peptides and Single Domain Antibodies for Cancer Therapy”

ADVISOR Kun Cheng, Ph.D.

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Chien-Yu Lin

DISSERTATION TITLE “Targeting Extracellular Matrix Using siRNA for the Treatment of Liver Fibrosis and Pancreatic Cancer”

ADVISOR Kun Cheng, Ph.D.

CAREER PLACEMENT Postdoctoral Associate, Lab of Kun Cheng, Ph.D., UMKC School of Pharmacy - Kansas City, Missouri

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Yanli Liu

DISSERTATION TITLE “Discovery of IKBKE and CD24 siRNAs for the Treatment of Triple-Negative Breast Cancer”

ADVISOR Kun Cheng, Ph.D.

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Umar-Farouk Mamani

DISSERTATION TITLE “Exploring Multivalency and Chemical Modifications in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy”

ADVISOR Kun Cheng, Ph.D.

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Nitish Mishra

DISSERTATION TITLE “Mitigating Antibiotic-Resistant Pathogens: A Multifaceted Strategy for Novel Antibacterial Drug Development and Comprehensive LCMS/MS Applications for Diverse Therapeutic Advancements”

ADVISOR William Gutheil, Ph.D.

CAREER PLACEMENT Scientist I, KCAS Bioanalytical and Biomarker Services - Olathe, Kansas

SEMESTER, YEAR GRADUATED FS23

STUDENT NAME Sherin George Shaji

DISSERTATION TITLE “Delivery of STING Agonist Using Lipid Nanoparticles and Discovery of Anti-TIGIT Peptides for Cancer Therapy”

ADVISOR Kun Cheng, Ph.D.

This year, the university conferred one Doctor of Philosophy degree in pharmacology:

2023 Career Placement Discipline of Pharmacology

SEMESTER, YEAR GRADUATED
STUDENT
NAME
DISSERTATION TITLE
ADVISOR
CAREER PLACEMENT
SP23

Daniel Schwartz

“ETOH/HIV-Induced Neurodeficit and cumvention by Neuroprotective Agent”

Jianping Wang, Ph.D.

Clinical Laboratory Scientist (CLS) III, St. Joseph Medical Center - Kansas City, Missouri

SEMESTER, YEAR GRADUATED SP23
STUDENT NAME Daniel Schwartz
DISSERTATION TITLE “ETOH/HIV-Induced Neurodeficit and cumvention by Neuroprotective Agent”
ADVISOR Jianping Wang, Ph.D.
CAREER PLACEMENT Clinical Laboratory Scientist (CLS) III, St. Joseph Medical Center - Kansas City, Missouri

BY THE NUMBERS

Doctor of Philosophy, 2023

2023 Graduate Student Data


PHARMACEUTICAL

SCIENCES

Enrollment as of Fall 2023

Average enrollment over the last five years

PHARMACOLOGY

Enrollment as of Fall 2023

Average enrollment over the last five years

Doctor of Pharmacy Class of 2027


Accepted Applicants

Applicants Matriculated

Average Age

%

Female

%

Male

%

Resident of Missouri

%

Previous Baccalaureate Degree

.52

Average GPA

Doctor of Pharmacy Class of 2023


.5%

On-Time Graduation Rate

.5%

NAPLEX first-time pass rate (5-year average)

.6%

MPJE first-time pass rate (5-year average)

POST-GRADUATE

PLACEMENT

%

Employment

%

Residency or Fellowship

%

Unknown

Doctor of Pharmacy Class of 2027


%

First-generation college student

%

Underrepresented minority student

%

Multilingual students

STATES REPRESENTED BY STUDENT:

Blue illustrated state outlines map of Arkansas, Kansas, Missouri, Nebraska, Oklahoma and Wisconsin

•Arkansas •Kansas •Missouri •Nebraska •Oklahoma •Wisconsin

UMKC RESIDENCY MATCH APPLICANTS

UMKC APPLICANTS MATCHED

%

UMKC SOP RESIDENCY MATCH RATE

%

NATIONAL RESIDENCY MATCH RATE

Title page
Contents
Back to top